These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 22336225)

  • 41. Erythroleukemia cell lines HEL and K-562: changes in isoenzyme profiles and morphology during induction of differentiation.
    Drexler HG; Gaedicke G; Minowada J
    Hematol Oncol; 1986; 4(2):163-74. PubMed ID: 3462117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Carbon 21 Steroidal Glycoside with Pregnane Skeleton from
    Yang J; Pan C; Pan Y; Hu A; Zhao P; Chen M; Song H; Li Y; Hao X
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EloA promotes HEL polyploidization upon PMA stimulation through enhanced ERK1/2 activity.
    Hu L; Zhang W; Xiang Z; Wang Y; Zeng C; Wang X; Tan C; Zhang Y; Li F; Xiao Y; Zhou L; Li J; Wu C; Xiang Y; Xiang L; Zhang X; Wang X; Yang W; Chen M; Ran Q; Li Z; Chen L
    Platelets; 2022 Jul; 33(5):755-763. PubMed ID: 34697988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in isoenzyme patterns expressed by the erythroleukemia cell lines K-562 and HEL after induction of differentiation.
    Drexler HG; Otsuka K; Martin PJ; Gaedicke G; Minowada J
    Haematol Blood Transfus; 1985; 29():430-2. PubMed ID: 3861485
    [No Abstract]   [Full Text] [Related]  

  • 45. Vimentin in human erythroleukemia (HEL) cells is modulated with differentiation inducers.
    Järvinen M
    Cell Biol Int Rep; 1990 Mar; 14(3):199-209. PubMed ID: 2188740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of an HEL-derived cell line expressing high levels of platelet factor 4.
    Ravid K; Kuter DJ; Beeler DL; Doi T; Rosenberg RD
    Blood; 1993 Jun; 81(11):2885-90. PubMed ID: 8499627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involvement of autophagy in diosgenin‑induced megakaryocyte differentiation in human erythroleukemia cells.
    Diab D; Pinon A; Ouk C; Hage-Sleiman R; Diab-Assaf M; Liagre B; Leger DY
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34458927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demonstration of the TSP receptor on the surface of human erythroleukaemia cell line (HEL).
    Imamura N; Inada T; Mitasiwa DM; Kuramoto A
    Br J Haematol; 1989 Nov; 73(3):430-1. PubMed ID: 2481491
    [No Abstract]   [Full Text] [Related]  

  • 49. "Yap"-ing about the Antifibrotic Benefits of Prostacyclin.
    Huang SK
    Am J Respir Cell Mol Biol; 2019 May; 60(5):499-500. PubMed ID: 30562049
    [No Abstract]   [Full Text] [Related]  

  • 50. The extracellular sulfatase SULF2 promotes liver tumorigenesis by stimulating assembly of a promoter-looping GLI1-STAT3 transcriptional complex.
    Carr RM; Romecin Duran PA; Tolosa EJ; Ma C; Oseini AM; Moser CD; Banini BA; Huang J; Asumda F; Dhanasekaran R; Graham RP; Toruner MD; Safgren SL; Almada LL; Wang S; Patnaik MM; Roberts LR; Fernandez-Zapico ME
    J Biol Chem; 2020 Feb; 295(9):2698-2712. PubMed ID: 31988246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.
    Castle J; Morris K; Pritchard S; Kirwan CC
    PLoS One; 2017; 12(4):e0175647. PubMed ID: 28422972
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostacyclin receptor induces STAT1 and STAT3 phosphorylations in human erythroleukemia cells: a mechanism requiring PTX-insensitive G proteins, ERK and JNK.
    Lo RK; Wise H; Wong YH
    Cell Signal; 2006 Mar; 18(3):307-17. PubMed ID: 15979846
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells.
    Shen HW; Chen YL; Chern CY; Kan WM
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):231-6. PubMed ID: 17481561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. RAD001-mediated STAT3 upregulation and megakaryocytic differentiation.
    Su YC; Li SC; Peng HY; Ho YH; Chen LJ; Liao HF
    Thromb Haemost; 2013 Mar; 109(3):540-9. PubMed ID: 23329056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostacyclin receptor regulation--from transcription to trafficking.
    Midgett C; Stitham J; Martin K; Hwa J
    Curr Mol Med; 2011 Oct; 11(7):517-28. PubMed ID: 21707517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.
    Lau AH; Lai HK; Yeung BH; Leung SL; Tsang SY; Wong YH; Wise H
    Prostaglandins Leukot Essent Fatty Acids; 2012 Mar; 86(3):119-26. PubMed ID: 22336225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostacyclin receptor-induced STAT3 phosphorylation in human erythroleukemia cells is mediated via Galpha(s) and Galpha(16) hybrid signaling.
    Lo RK; Liu AM; Wise H; Wong YH
    Cell Signal; 2008 Nov; 20(11):2095-106. PubMed ID: 18755267
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.